CBI-1214 T Cell Engager
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CBI-1214 T Cell Engager, covering 2026-03-03 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer [Phase 1]